Future directions for anti-biofilm therapeutics targeting Candida.
about
An Integrated Modeling and Experimental Approach to Study the Influence of Environmental Nutrients on Biofilm Formation of Pseudomonas aeruginosa.Evidence for a Pneumocystis carinii Flo8-like transcription factor: insights into organism adhesionInhibitory Effect of Sophorolipid on Candida albicans Biofilm Formation and Hyphal Growth.Garcinia xanthochymus Benzophenones Promote Hyphal Apoptosis and Potentiate Activity of Fluconazole against Candida albicans BiofilmsCharacterization of a novel antibiofilm effect of nitric oxide-releasing aspirin (NCX-4040) on Candida albicans isolates from denture stomatitis patients.Exploiting Interkingdom Interactions for Development of Small-Molecule Inhibitors of Candida albicans Biofilm Formation.Distribution and Drug Susceptibility of Candida spp. Associated With Female Genital Tract Infection, Chongqing, China.Combinatorial drug approaches to tackle Candida albicans biofilms.Polymicrobial Candida biofilms: friends and foe in the oral cavity.Future therapies targeted towards eliminating Candida biofilms and associated infections.Fungal Biofilms: Update on Resistance.In vitro Effects of Lemongrass Extract on Candida albicans Biofilms, Human Cells Viability, and Denture Surface.Probiotic lactobacilli inhibit early stages of Candida albicans biofilm development by reducing their growth, cell adhesion, and filamentation.Antifungal Potential of Copper(II), Manganese(II) and Silver(I) 1,10-Phenanthroline Chelates Against Multidrug-Resistant Fungal Species Forming the Candida haemulonii Complex: Impact on the Planktonic and Biofilm Lifestyles.Effect of algae and plant lectins on planktonic growth and biofilm formation in clinically relevant bacteria and yeasts.Critical role for CaFEN1 and CaFEN12 of Candida albicans in cell wall integrity and biofilm formation.Detection and quantification of fluconazole within Candida glabrata biofilms.Anti-biofilm activity of a sophorolipid-amphotericin B niosomal formulation against Candida albicans.The Interface between Fungal Biofilms and Innate Immunity.Fungal Biofilms and Polymicrobial Diseases.Recent Advancements in Combinational Antifungal Therapy and Immunotherapy
P2860
Q30405305-54D73DE2-DDCE-40FD-B12F-7844CAC60019Q35717316-1C5E7765-A30C-4064-931C-60524D4C2F67Q35974693-241DF9E0-7F65-498B-8E15-D4C82B297967Q36075771-434F8263-6FD0-4CF7-B504-D2CA476EAAB0Q36368948-AF207761-C448-4827-AE63-C58926B99B22Q37287904-83409D5E-A739-455C-8C88-E907A1AEEE08Q37589011-3F4904EE-1366-486B-BF8E-36CAA1522E66Q38526460-7C17447E-EF5E-4944-831E-AE9ECF2E48B5Q38571719-0D6FD29A-17B4-46C6-8FE4-9AFA5D91CFF8Q38786061-FD8B3F35-2DCB-429D-9354-837F708BC304Q38817837-CAD4BF78-8ABE-472A-8913-98806B0FC63CQ39571841-F5C00CF1-25F7-4EA5-A3BF-30C1E17F4F9FQ39844093-31FB1A2F-01DD-4667-83F7-279714B9567CQ40119738-54FE195D-1009-4F51-AEC8-0F0D70E54926Q40736284-FD892023-59C0-4DC9-928E-2992C4B3D62AQ41370356-62972567-15FB-426A-8DE3-1CB739745951Q41526027-6EA6C470-0BF4-4B0B-B9BD-4CD2C6338BF1Q47634017-0BA35BE6-CE2A-4925-AD06-A879E09D4959Q49203638-0D0F209C-E5BE-47B1-9421-B7F3123E45C0Q49679766-95A610C4-D618-40EF-A0D4-0EC55090D3C5Q57705351-785814DE-CFAF-4A57-B0B0-1E20B22BCD72
P2860
Future directions for anti-biofilm therapeutics targeting Candida.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Future directions for anti-biofilm therapeutics targeting Candida.
@en
type
label
Future directions for anti-biofilm therapeutics targeting Candida.
@en
prefLabel
Future directions for anti-biofilm therapeutics targeting Candida.
@en
P2860
P1476
Future directions for anti-biofilm therapeutics targeting Candida.
@en
P2093
Jeniel E Nett
P2860
P304
P356
10.1586/14787210.2014.885838
P577
2014-02-09T00:00:00Z